SHEPHERD Therapeutics


    SHEPHERD’s mission is to cure rare cancers. We work closely with rare-cancer specific disease foundations to identify and pursue the highest potential translational science. We then leverage those relationships to run clinical trials which are finely attuned to the specific needs of rare cancer patients. Our platform-agnostic approach allows us to select the most technologically innovative solutions for patients and to diversify our portfolio of lead compounds across rare cancers, therapeutic platforms, and partnership and licensing structures.